Codeine cough syrups may do more harm than good

Image
Press Trust of India London
Last Updated : Dec 23 2015 | 5:07 PM IST
Doctors have issued a warning about excessive use of over-the-counter cough medicines containing codeine, after a healthy 14-year-old girl experienced confusion and loss of the ability to create new memories.
Researchers from Letterkenny General Hospital and National University of Ireland, described the first published case of confusional state in the teenage girl attributed to excessive consumption of cough medicine containing codeine.
Codeine is a widely prescribed painkiller, but it can also be purchased over the counter in preparations of cold/cough remedies.
However, doctors warn that there is little evidence showing benefits of codeine in cough remedies, and the risks associated with codeine use in cough suppressants may be "particularly unnecessary" because of the lack of evidence.
Codeine intoxication symptoms often include central nervous system depression, respiratory depression, severe itching of the skin, and flushing. Confusion is a relatively unusual complaint, researchers said.
However, in this particular case, the teenage girl experienced confusion and the loss of the ability to create new memories.
She falsely reported to have completed tasks, for example, by claiming to have showered when it was obvious to her mother that she had not. In addition, she switched languages during her homework, the researchers said.
She slept up to 20 hours a day, had a decreased attention span and suffered from intermittent headaches.
Before these symptoms, the patient experienced flu-like symptoms over a 15 day period, during which she was absent from school.
She had been taking 2-3 spoonfuls daily of codeine cough suppressant, oral codeine phosphate, over this time.
The patient had not exceeded the recommended daily dosage of 3-6 spoonfuls, but she had exceeded the maximum recommended duration of usage of 3 days.
Each spoonful is equivalent to 15 mg of codeine, and the patient consumed a total of 450-675 mg over 15 days, instead of the recommended maximum dosage of 270 mg during any given course of treatment. A urine test reported positive for codeine, and no other drugs were present.
The doctors warn that there have been many reported child and adolescent deaths following codeine use, and they conclude that "the combination of lack of efficacy, risk of acute intoxication and dependence, suggests that the use of OTC codeine preparations may be unwarranted."
The study was published in the journal BMJ Case Reports.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 23 2015 | 5:07 PM IST

Next Story